Abstract:Background: Anticoagulation management can effectively prevent complications in patients undergoing cardiac valve replacement (CVR). The emergence of eHealth tools provides new prospects for the management of long-term anticoagulants. However, there is no comprehensive summary of the application of eHealth tools in anticoagulation management after CVR. Objective: Our objective is to clarify the current state, trends, benefits, and challenges of using eHealth tools in the anticoagulation management of patients after CVR and provide future directions and recommendations for development in this field. Methods: This scoping review follows the 5-step framework developed by Arksey and O'Malley. We searched 5 databases such as PubMed, MEDLINE, Web of Science, CINAHL, and Embase using keywords such as "eHealth," "anticoagulation," and "valve replacement." We included papers on the practical application of eHealth tools and excluded papers describing the underlying mechanisms for developing eHealth tools. The search time ranged from the database inception to March 1, 2023. The study findings were reported according to the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews). Additionally, VOSviewer (version 1.6.18) was used to construct visualization maps of countries, institutions, authors, and keywords to investigate the internal relations of included literature and to explore research hotspots and frontiers. Results: This study included 25 studies that fulfilled the criteria. There were 27,050 participants in total, with the sample size of the included studies ranging from 49 to 13,219. The eHealth tools mainly include computer-based support systems, electronic health records, telemedicine platforms, and mobile apps. Compared to traditional anticoagulation management, eHealth tools can improve time in therapeutic range and life satisfaction. However, there is no significant impact observed in terms of economic benefits and anticoagulation-related complications. Bibliometric analysis suggests the potential for increased collaboration and opportunities among countries and academic institutions. Italy had the widest cooperative relationships. Machine learning and artificial intelligence are the popular research directions in anticoagulation management. Conclusions: eHealth tools exhibit promise for clinical applications in anticoagulation management after CVR, with the potential to enhance postoperative rehabilitation. Further high-quality research is needed to explore the economic benefits of eHealth tools in long-term anticoagulant therapy and the potential to reduce the occurrence of adverse events.

Progress on low molecular weight heparin for patients with heart valve replacement

Research Progress of Low Molecular Weight Heparin

Efficacy Observation of Bridging Anticoagulation of Low Molecular Weight Heparin after Cardic Valve Replacement in the Early Stage

Low Molecular Weight Heparin for the Prevention of Venous Thromboembolism after General Surgery

Comparison of Low-Molecular-weight-heparin and Unfractionated Heparin for Acute PTE

Non-Anticoagulant Activities of Low Molecular Weight Heparins—A Review

[Clinical Study of Anticoagulation with Warfarin and Heparin in Patients after Mechanical Valve Replacement].

[Low-Molecular-weight Heparin for Preventing Deep-Vein Thrombosis after Total Joint Arthroplasty].

Low-molecular-weight heparin in the prevention of venous thromboembolism among patients with acute intracerebral hemorrhage: A meta-analysis

Safety of Preoperative Heparin for Prevention of Thrombus in Patients Undergoing Thoracoscopic Surgery

Application of low molecular weight heparins in umbilical artery thrombosis: A case series and review of the literature.

Low Molecular Weight Heparin for the Prevention of Deep Venous Thrombosis after Total Knee Arthroplasty: A Systematic Review and Meta-Analysis

Inverse Relationship of Bleeding Risk with Clot Burden During Pulmonary Embolism Treatment with LMW Heparin.

Efficacy and Safety Study on Low Molecular Heparin in the Prevention for Venous Thromboembolism Prophylaxis after Spontaneous Intracerebral Hemorrhage

Low Molecular Weight Heparin Versus Other Anti-Thrombotic Agents for Prevention of Venous Thromboembolic Events after Total Hip or Total Knee Replacement Surgery: a Systematic Review and Meta-Analysis

Late dysfunction of a mechanical aortic valve after long-term low molecular weight heparin therapy: a case report

Combining Portable Coagulometers with the Internet: A New Model of Warfarin Anticoagulation in Patients Following Mechanical Heart Valve Replacement

Dosing practice of low molecular weight heparins and its efficacy and safety in cardiovascular inpatients: a retrospective study in a Chinese teaching hospital

Low-Molecular-Weight Heparin Versus Aspirin in Early Management of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis

Application of eHealth Tools in Anticoagulation Management After Cardiac Valve Replacement: Scoping Review Coupled With Bibliometric Analysis

Low-molecular-weight heparin reduces the formation of lower limb deep venous thrombosis in patients with hypertensive intracerebral hemorrhage